To help clinicians

71
НА ДОПОМОГУ КЛІНІЦИСТУ / TO HELP CLINICIANS
phic cardiomyopathy // Amer. J. Cardiol. — 2013. — Vol. 111. — 
P. 1784-1791.
37. Kumar K.R., Mandleywala S.N., Link M.S. Atrial and 
ventricular arrhythmias in hypertrophic cardiomyopathy // Card. 
Electrophysiol. Clin. — 2015. — Vol. 7(2). — P. 173-186.
38. Lovelock J.D., Monasky M.M., Jeong E.M. et al. Ra-
nolazine improves cardiac diastolic dysfunction through modula-
tion of myofilament calcium sensitivity // Circ. Res. — 2012. — 
№ 110. — Р. 841-50.
39. Macintyre C., Lakdawala N.K. Management оf atrial 
fibrillation in hyperthrophic cardiomyopathy // Circulation. — 
2016. — Vol. 133. — P. 1901-1905.
40. Maciver D.H. A new method for quantification of left ven-
tricular systolic function using a corrected ejection fraction // Eur. 
J. Echocardiogr. — 2011. — № 12. — Р. 228-234.
41. Madias J.E. Electrocardiogram in apical hypertrophic 
cardiomyopathy with a speculation as to the mechanism of its fea-
tures // Neth. Heart J. — 2013. — Vol. 21(6). — P. 268-271.
42. Maron M.S., Rowin E.J., OLivotto I. et al. Contemporary 
natural history and management of nonobstructive hypertrophic 
cardiomyopathy // J. Amer. Coll. Cardiol. — 2016. — Vol. 67. — 
P. 1399-1409.
43. Minami Y., Haruki S., Hagiwara N. et al. Phenotypic 
overlap in hypertrophic cardiomyopathy: Apical hypertrophy, 
midventricular obstruction, and apical aneurysm // Journal of 
Cardio logy. — 2014. — Vol. 64. — P. 463-469.
44. Okishige K., Sasano T., Yano K. et al. Serious arrhyth-
mias in patients with apical hypertrophic cardiomyopathy // In-
tern. Med. — 2001. — № 40. — Р. 396-402.
45. Olivotto I., Hellawell J.L., Farzaneh-Far R. et al. Novel 
approach targeting the complex pathophysiology of hypertrophic 
cardiomyopathy: the Impact of Late Sodium Current Inhibition 
on Exercise Capacity in Subjects with Symptomatic Hypertrophic 
Cardiomyopathy (LIBERTY-HCM) Trial // Circ. Heart Fail. — 
2016. — № 9. — Р. e002764.
46. Olivotto I., Cecchi F., Casey S.A. et al. Impact of atrial 
fibrillation on the clinical course of hyperthrophic cardiomyopa-
thy // Circulation. — 2001. — Vol. 104. — P. 2517-2524.
47. Ozekea O., Ertanb C., Keskin G. et al. Association of ST 
elevation with apical aneurysm in hypertrophic cardiomyopathy // 
Indian. Heart Journal. — 2015. — Vol. 67. — P. 434-439.
48. Park K.M., Im S.I., Kim E.K. et al. Atrial fibrillation in 
hypertrophic cardiomyopathy: is the extent of septal hypertrophy 
important? // PLoS One 2016. — Vol. 11(6). — Р. eO156410.
49. Patel J., Michaels J., Mieres J. et al. Echocardiography 
diagnosis of apical hypertrophic cardiomyopathy with optison con-
trast // Echocardiography. — 2002. — № 19. — Р. 521-524.
50. Sakamoto T., Amano K., Hada Y. et al. Asymmetric 
apical hypertrophy, ten years experience // Postgrad. Med. J. — 
1986. — Vol. 62. — P. 567-570.
51. Sakamoto T., Tei C., Muravama M. et al. Giant T wave 
inversion as a manifestation of asymmetrical apical hypertrophy 
(AAH) of the left ventricle: Echocardiography and ultrasono-
cardiotomographic study // Jpn. Heart J. — 1976. — Vol. 17. — 
P. 611-629.
52. Semsarian C., Ingles J., Maron M.S. et al. New Per-
spectives on the Prevalence of Hypertrophic Cardiomyopathy // 
JACC. — 2015. — Vol. 65, № 12. — P. 1249-1254.
53. Siontis K.C., Geske J.B., Ong K. et al. Atrial fibrillation 
in hypertrophic cardiomyopathy: prevalence, clinical correlations, 
and mortality in a large high — risk population // J. Am. Heart 
Assoc. — 2014. — Vol. 3. — Р. e001002.
54. Spirito P., Autore C. Apical hypertrophic cardiomyopathy 
or left ventricular non-compaction? A difficult differential diagno-
sis // Eur. Heart J. — 2007. — Vol. 28(16). — P. 1923-1924. 
55. Spoladore R., Maron M.S., D’Amato R. et al. Pharma-
cological treatment options for hypertrophic cardiomyopathy: high 
time for evidence // Eur. Heart J. — 2012. — Vol. 33. — P. 1724-
1733.
56. Stainback R.F. Apical Hypertrophic Cardiomyopathy // 
Tex. Heart Inst. J. — 2012. — Vol. 39(5). — P. 747-749. 
57. Suganuma Y., Shinmura K., Hascgawa H. et al. Clinical 
characteristics and cardiac events in elderly patients with apical 
hypertrophic cardiomyopathy // Nippon Ronen Igakkai Zasshi. — 
1997. — № 34. — Р. 474-481.
58. Thyagarajan B., Kalra A., Rajabali A. et al. Subclinical 
atrial fibrillation in patients with hypertrophic cardiomyopathy // 
US Cardiology Review. — 2016. — Vol. 10(2). — P. 75-77.
59. Urbano-Moral J.A., Rowin E.J., Maron M.S. et al. In-
vestigation of global and regional myocardial mechanics with 
3-dimensional speckle tracking echocardiography and relations to 
hypertrophy and fibrosis in hypertrophic cardiomyopathy // Circ. 
Cardiovasc. Imaging. — 2014. — Vol. 7. — P. 11-19.
60. Wijeyeratne Y.D. Arrhythmias in hypertrophic cardio-
myopathy and 2014 ESC Guidelines // British Heart Rhythm. 
Society. Editorial. — 2015. — http://www.bhrs.com/editorial-
arrhythmias-in-hypertrophic-cardiomyopathy.
61. Yamaguchi H., lshimura T., Nishiyama S. et al. Hy-
pertrophic nonobstructive cardiomyopathy with giant negative T 
waves (apical hypertrophy): ventriculographic and echocardio-
graphic features in 30 patients // Amer. J. Cardiol. — 1979. — 
Vol. 44. — P. 401-412.
62. Yusuf S., Bathina J., Banchs J. et al. Apical hypertrophic 
cardiomyopathy // World J. Cardiol. — 2011. — Vol. 26; 3(7). — 
P. 256-259.
63. Zhou X.H., Peng Z.P., Peng Q. et al. Clinical application 
of 64-slice spiral CT for apical hypertrophic cardiomyopathy // 
Chin. J. of Radiol. — 2008. — № 42. — Р. 911-915.
Получено 16.02.2017 
Несукай О.Г., Адаричев В.В., Титов Є.Ю., Гіреш І.І.
ДУ «ННЦ «Інститут кардіології імені академіка 
М.Д. Стражеска» НАМН України», м. Київ, Україна